| Development of a therapeutic monoclonal antibody targeting secreted aP2 to treat type 2 diabetes. | |
Heteromer
| 1-132 | 100 | 1×SO4; |
|
| Development of a monoclonal antibody targeting secreted aP2 to treat diabetes and fatty liver disea… | |
Heteromer
| 2-132 | 100 | |
|
| Troglitazone Bound to Fatty Acid Binding Protein 4 | | homo-2-mer | 1-132 | 100 | 3×SO4; 2×TDZ; |
|
| THE ADIPOCYTE LIPID-BINDING PROTEIN AT 1.6 ANGSTROMS RESOLUTION: CRYSTAL STRUCTURES OF THE APOPROTE… | | homo-2-mer | 2-132 | 100 | 2×OLA; |
|
| X-RAY CRYSTALLOGRAPHIC STRUCTURES OF ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH PALMITATE AND H… | | homo-2-mer | 2-132 | 100 | 2×PLM; 2×PPI; |
|
| THE ADIPOCYTE LIPID-BINDING PROTEIN AT 1.6 ANGSTROMS RESOLUTION: CRYSTAL STRUCTURES OF THE APOPROTE… | | homo-2-mer | 2-132 | 100 | 2×STE; |
|
| ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH ARACHIDONIC ACID: X-RAY CRYSTALLOGRAPHIC AND TITRATI… | | homo-2-mer | 2-132 | 100 | 2×ACD; 2×PPI; |
|
| X-RAY CRYSTALLOGRAPHIC STRUCTURES OF ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH PALMITATE AND H… | | homo-2-mer | 2-132 | 100 | 2×HDS; 2×PPI; |
|
| THE ADIPOCYTE LIPID-BINDING PROTEIN AT 1.6 ANGSTROMS RESOLUTION: CRYSTAL STRUCTURES OF THE APOPROTE… | | homo-2-mer | 2-132 | 100 | |
|
| Crystal structure of adipocyte fatty acid binding protein covalently modified with 4-hydroxy-2-none… | | homo-2-mer | 2-132 | 99.24 | 1×PO4; |
|
| Crystal structure of adipocyte fatty acid binding protein non-covalently modified with 4-hydroxy-2-… | | homo-2-mer | 2-132 | 100 | 2×CL; 2×HNE; 8×PO4; |
|
| Linoleic Acid Bound to Fatty Acid Binding Protein 4 | | homo-2-mer | 2-132 | 100 | 2×SO4; 2×EIC; |
|
| PYRIDOXAMINE MODIFIED MURINE ADIPOCYTE LIPID BINDING PROTEIN | | homo-2-mer | 2-132 | 100 | 2×CL; |
|
| PHENANTHROLINE MODIFIED MURINE ADIPOCYTE LIPID BINDING PROTEIN | | homo-2-mer | 2-132 | 100 | |
|
| ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH 1-ANILINO-8-NAPHTHALENE SULFONATE | | homo-2-mer | 2-132 | 100 | 1×CL; 2×2AN; |
|
| C1G/V32D/F57H MUTANT OF MURINE ADIPOCYTE LIPID BINDING PROTEIN AT PH 4.5 | | homo-2-mer | 3-132 | 98.46 | |
|
| V32D/F57H MUTANT OF MURINE ADIPOCYTE LIPID BINDING PROTEIN | | homo-2-mer | 3-132 | 98.46 | |
|
| Crystal Structure of apo mouse FABP4, C-centered orthorhombic form | | monomer | 1-132 | 100 | 1×FLC; |
|
| Crystal Structure of apo mouse FABP4 | | monomer | 1-132 | 100 | |
|
| Toward changing specificity: adipocyte lipid binding protein mutant, apo form | | monomer | 2-132 | 97.71 | 1×PO4; |
|
| Identification and Characterization of a Small Molecule Inhibitor of Fatty Acid Binding Proteins | | monomer | 2-132 | 100 | 1×B64; |
|
| Toward changing specificity: adipocyte lipid binding protein mutant, oleic acid bound form | | monomer | 2-132 | 97.71 | 1×PO4; 1×OLA; |
|
| CRYSTAL STRUCTURE OF RECOMBINANT MURINE ADIPOCYTE LIPID-BINDING PROTEIN | | monomer | 2-132 | 100 | |
|